Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • New Data Show Power Limits of Bluebird’s Gene Therapy For Blood Diseases

    Nov 3, 2016, 09:48 AM by Michael Croft
    Xconomy | Bluebird Bio is releasing new data this morning that speak to both the potential and the limitations of a gene therapy it's been developing for two deadly blood diseases: sickle cell disease and beta-thalassemia.
    Full story
  • The Pistoia Alliance Calls for Greater Collaboration on Wearable Devices in R&D

    Nov 2, 2016, 09:43 AM by Michael Croft
    LONDON, UNITED KINGDOM - Nov 2, 2016 -  The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, is calling on the pharmaceutical industry to support greater collaboration around wearable device initiatives
    Full story
  • Recipharm invests in its Italian API facility

    Nov 2, 2016, 07:14 AM by Michael Croft
    PADERNO DUGNANO, ITALY - Nov 2, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has announced an investment of over €1
    Full story
  • Repositive Announce Launch of Microbiome Data Collection

    Nov 2, 2016, 05:34 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Nov 2, 2016 - Repositive, a software company developing novel tools to improve discovery and access to human genomic research data, has expanded its Specialised Data Collections, with the addition of microbiome data
    Full story
  • Optibrium And Collaborative Drug Discovery Integrate StarDrop With CDD Vault

    Nov 1, 2016, 15:35 PM by Michael Croft

    Bio-IT World News Brief | Optibrium and Collaborative Drug Discovery announced a collaboration to integrate the StarDrop and CDD Vault platforms. This creates a connection in real time between project data, securely held and managed in CDD Vault, and StarDrop’s unique compound design and optimization capabilities. 

    Full story
  • Young Scientists Ditch Postdocs for Biotech Start-Ups

    Nov 1, 2016, 12:01 PM by Michael Croft
    Nature News & Comment | Many biologists are founding their own firms as venture capitalists show increased interest in science.
    Full story
  • Danforth Plant Science Center Develops Versatile Field Phenotyping to Benefit Farmers

    Nov 1, 2016, 11:54 AM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Nov 1, 2016 -                            Solar-powered PheNode is set for investment stage.Researchers at the Donald Danforth Plant Science Center, a not-for-profit research institute with a mission to improve the human condition through plant science, are leveraging expertise in crop phenotyping with the development of the PheNode, a 'smart', farm-ready, solar-powered environmental sensor and phenotyping station for crops
    Full story
  • FactBio Announces Improvements to the Kusp Data Curation Platform

    Nov 1, 2016, 05:55 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Nov 1, 2016 - FactBio, has launched Kusp 1.1, an update to its data curation platform which sees a number of new key features added
    Full story
  • Smarter ELNs and Smarter Labs Make for Smarter Science

    Oct 31, 2016, 16:10 PM by Michael Croft

    Bio-IT World | New technology, new laws and regulations, and more cumbersome "Big Data" have together caused the standard, traditional electronic lab notebook (ELN) to obsolesce.  But some experts believe new digital-transformation technology—including the Internet of Things and cloud computing—will allow for enhanced ELNs that can address today's clinical pain points of efficiency, ROI, scientific contextual consistency, and risk reduction.

    Full story
  • Mark Zuckerberg Is Funding a Facebook for Human Cells

    Oct 31, 2016, 15:00 PM by Michael Croft
    MIT Technology Review | The billionaire is the first major donor to back the idea of creating an atlas of all human cells.
    Full story
  • Third Rock Ventures One of Biotechs Daring Investors Raises $616M For More Startups

    Oct 31, 2016, 11:52 AM by Michael Croft
    Forbes | Biotech venture capital is supposed to be the highest-risk/highest-reward type of investment there is. But many biotech VCs are actually pretty conservative, hesitant to wager on edgy science that might take a decade to pay off. Not Third Rock Ventures.
    Full story
  • Onboarding New Talent Post-IPO Turnover Of Biotech Boards

    Oct 31, 2016, 10:55 AM by Michael Croft
    Forbes | A biotech's Board often plays important roles in shaping the company's success or failure: contributing strategic guidance, providing proper governance, stewarding fiduciary responsibilities, raising a startups' profile, aiding business development, to name a few.
    Full story
  • Nation’s Report Card Shows Improvement In Science, But There’s Still Work To Do

    Oct 28, 2016, 13:15 PM by Michael Croft

    Bio-IT World | The White House released the National Assessment of Educational Progress, their report card for the nation’s educational systems. In the field of science, Tennessee was among the standouts of those recognized.

    Full story
  • Oxford Genetics receives £1m investment

    Oct 28, 2016, 11:29 AM by Michael Croft
    OXFORD, OXFORD - Oct 28, 2016 - A leading biotechnology company with expertise in DNA design is set to benefit from a £1m investment to support its growth strategy and assist in the delivery of new services for cancer fighting gene therapy technologies
    Full story
  • Internet2, Google, BGI, and More: News from October 2016

    Oct 28, 2016, 10:35 AM by Michael Croft

    Bio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from Internet2, Google, BGI, and more.

    Full story
  • Cardiac Assist Devices Market to be Propelled by Rapidly Growing Geriatric Population

    Oct 28, 2016, 07:22 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Oct 28, 2016 - Cardiac Assist Devices (CAD) are type of mechanical pumps that work along with the heart to improve its pumping efficiency and maintain the optimum blood flow throughout the body
    Full story
  • Sterilization Market is Driven with Rise in Safety Processes of Various Research Laboratories

    Oct 28, 2016, 03:48 AM by Michael Croft
    ALBANY, NY - Oct 28, 2016 - The term sterilization refers to any procedure that helps in destroying all forms of microbial life and transmissible agents
    Full story
  • New ZEISS Axio Observer Microscopes for Life Sciences

    Oct 27, 2016, 09:31 AM by Michael Croft
     The open and flexible inverted microscope platform for living and fixed specimens Jena, Germany, 10 26 2016 Today, ZEISS introduces a new inverted microscope platform for life science research. The ZEISS Axio Observer family consists of
    Full story
  • Hemophilia Treatment Market is Unearthed through Growing Number of R & D Projects in Sector

    Oct 27, 2016, 08:40 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Oct 27, 2016 - The research report on the global hemophilia treatment market provides every detail that is critical in understanding the nature of the changing market dynamics
    Full story
  • Creative Biolabs Announces a Satisfactory Result in Its Research Cooperation with In-Cell-Art

    Oct 26, 2016, 22:18 PM by Michael Croft
    SHIRLEY, NY, USA - Oct 27, 2016 - Creative Biolabs, a biotech company specialized in providing custom biotechnology and pharmaceutical services that cover the full scope of biotechnology needs, announces that its services provided to In-Cell-Art (ICA) lead to a satisfactory result in the research collaboration between ICA and Virbac
    Full story
  • «
  • 341
  • 342
  • 343 (current)
  • 344
  • 345
  • 346
  • 347
  • 348
  • 349
  • 350
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy